NEWYORK (Reuters Health) - Oral contraceptives with low levels ofestrogenand progestin reduce the risk of ovarian cancer even more thanolderversions of the Pill, according to investigators at theUniversity ofHawaii in Honolulu.
NEWYORK (Reuters Health) - Oral contraceptives with low levels ofestrogenand progestin reduce the risk of ovarian cancer even more thanolderversions of the Pill, according to investigators at theUniversity ofHawaii in Honolulu.
据纽约（路透社健康频道）报道——檀香山的夏威夷大学研究者指出，低含量雌激素和黄体酮的口服避孕药比旧的药丸更能降低患卵巢癌的风险。